Qinlock
Payments companies reported to CMS as associated with Qinlock. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Qinlock, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Qinlock
These are the largest totals companies reported as associated with Qinlock. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Agulnik | Los Angeles, CA | Medical Oncology | $56,195.43 |
| Arlene Ortega | San Diego, CA | Nurse Practitioner | $47,167.99 |
| Ciara Kelly | New York, NY | Medical Oncology | $38,993.43 |
| John Charlson | Milwaukee, WI | Hematology & Oncology | $37,643.23 |
| Arun Singh | Santa Monica, CA | Hematology & Oncology | $33,279.30 |
| Seth Pollack | Chicago, IL | Hematology & Oncology | $26,035.19 |
| Gina D Amato | Atlanta, GA | Hematology & Oncology | $19,899.34 |
| Rebecca Ganzon | Pickerington, OH | Adult Health (Nurse Practitioner) | $19,054.82 |
| Atrayee Basu Mallick | Philadelphia, PA | Hematology & Oncology | $18,391.29 |
| Morgan Mount | Miami, FL | Family | $16,393.48 |
Prescribed Qinlock?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.